I was expecting a reacceleration of growth for UiPath in the second half of FY2023 — management expects otherwise. Short-term macro uncertainty and weaker-than-expected guidance led to investors ...

Initiate on UiPath Inc. at Neutral with a $15 PT, citing resilient cloud ARR growth and enterprise customer expansion, but competitive intensity and CEO transition limit near-term upside. FY26E and ...

Palantir’s revenue accelerated again as its profits soared. UiPath’s growth stalled out as it faced macro and competitive challenges. The pricier stock should be the better buy for the foreseeable ...

UiPath (NYSE: PATH) is a tiny company compared to Microsoft. The stock of the maker of robotic process automation (RPA) software is only worth $7.2 billion, while the diversified tech titan is worth a ...

Raimo Lenschow, an analyst from Barclays, maintained the Hold rating on UiPath (PATH – Research Report). The associated price target is $25.00. Raimo Lenschow’s rating is based on UiPath’s performance ...

UiPath Inc. (NYSE: PATH) was recently added to the S&P MidCap 400 index, replacing Synovus Financial Corp., reflecting the automation company's increased scale and market presence. This index ...

Automation software company UiPath (NYSE:PATH) will be announcing earnings results this Wednesday after the bell. Here’s what to look for. UiPath beat analysts’ revenue expectations by 4.1% last ...

UiPath helps companies automate tasks traditionally performed by human employees with software robots. The slower-growth ...

Palantir (NYSE: PLTR) and UiPath (NYSE: PATH) represent two different ways to invest in the growing artificial intelligence (AI) market. Palantir mines data from disparate sources to help its ...

Palantir is growing like a weed, but its valuations are getting overheated. UiPath faces tough near-term challenges, but its stock looks a lot cheaper. Both stocks are risky plays in this frothy ...